Author + information
- Received August 18, 1983
- Revision received October 11, 1983
- Accepted October 14, 1983
- Published online March 1, 1984.
- Peter R. Kowey, MD, FACCa,
- Ted Friehling, MD,
- Steven G. Meister, MD, FACC and
- Toby R. Engel, MD, FACC
- ↵aAddress for reprints: Peter R. Kowey, MD, Department of Medicine, the Medical College of Pennsylvania, 3300 Henry Avenue, Philadelphia, Pennsylvania 19129.
A prospective study was made of 57 asymptomatic patients, 1 to 24 months after acute myocardial infarction, 17 with (Group I) and 40 without (Group II) ventricular fibrillation during the acute event. None of the 57 patients had symptomatic arrhythmias, uncontrolled heart failure or unstable angina. There was no significant difference between the two patient groups in time from acute myocardial infarction, medication used or left ventricular ejection fraction. Repetitive forms of arrhythmia (Lown grade 4) were more prevalent (29 versus 16%, not significant) during 24 hour ambulatory monitoring in patients in Group I (ventricular fibrillation group).
Programmed extrastimulation was performed using 1 to 3 twice-threshold, 2 ms decremental extrastimuli delivered during right ventricular drive. Of the 17 patients in Group I, 8 had no induced arrhythmia (≤ 4 extra responses), 4 had nonsustained ventricular tachycardia and 5 bad sustained ventricular tachycardia (degenerating into ventricular fibrillation requiring eleco trical reversion in 4). None of the 40 patients in Group II had induced sustained ventricular tachycardia (p < 0.005), although 9 had nonsustained ventricular tachycardia.
Patients with ventricular fibrillation during acute myocardial infarction may have an increased risk for ventricular tachycardia or ventricular fibrillation that may be exposed by programmed electrical stimulation even when not yet clinically manifest.
This study was supported in part by Grants HL28903 and HL27665 from the National Institutes of Health, Bethesda, Maryland. Dr. Kowey is the recipient of a New Investigator Award from the National Heart, Lung, and Blood Institute, National Institutes of Health. This study was presented in part at the 55th Annual Scientific Sessions of the American Heart Association, Dallas, Texas, November 1982.
- Received August 18, 1983.
- Revision received October 11, 1983.
- Accepted October 14, 1983.
- American College of Cardiology Foundation